You are here

• Home
• Therapy Areas
• Gastrointestinal

• A Randomized, Open-Label Study to Evaluate the Pharmacokinetics of Single Oral Doses of Esomeprazole Magnesium in Pediatric Patients 1 to 11 Years-Old Inclusive with Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)

Disease

gastrointestinal diseases

Drug Name

Nexium

Generic Name

esomeprazole

Sponsor

AstraZeneca

Drug Status

Approved Medicine

Phase

I

Start Date

Aug 14, 2006

Study Name

D9614C00007

Study Id

D9614C00007

ClinicalTrials.gov ID

NCT00687245

Recruiting Status

Closed

Protocol Status

Not Available

Report

Jan 18, 1971

• D9614C00007.pdf (30 KB)

Page tools

• Print
• Bookmark this page